Dosidal · Switzerland

Mometason-Mepha Nasenspray, Suspension

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:63248 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 63248
atc: R01AD09
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2014-02-07
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: R01AD09
authorisation_number: 63248
form: NASSS
holder: Mepha Pharma AG
holder_partner_nr: 1006155
it_number: 12.02.3.
name: Mometason-Mepha Nasenspray, Suspension
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
2vAC15nCkXtiD2XCIhGwYfA3YN7u1JqjfyELCp8ip2RDkWOdbh04DzT1i5uvbIujukHH9_WDsghciL50Ny6GVw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal